| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-10 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-10 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.3 | 6e-08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |